World

Vaccine names advance in Oxford study (NYSE: AZN)

Players of the coronavirus vaccine are on duty this morning before the results of the Phase 1 trial of AstraZeneca (NYSE: AZN) The COVID-19 vaccine developed with the University of Oxford, to be published in The lancet. Reports last week suggested the magazine would release positive news: The vaccine is …

Read More »